Skip to main content
logo
HEM Pharma Inc. (KOSDAQ:376270)
South Korea flag South Korea · Delayed Price · Currency is KRW
26,150
-950 (-3.51%)
At close: Oct 29, 2026

HEM Pharma Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Market Capitalization
188,519327,494114,874
Market Cap Growth
-7.72%185.09%-
Enterprise Value
200,214334,986-
Last Close Price
27100.0045850.0016500.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
PS Ratio
12.1025.237.62
PB Ratio
11.9162.804.40
P/TBV Ratio
15.2092.814.54

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
EV/Sales Ratio
12.8325.81-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Debt / Equity Ratio
1.183.690.30
Net Debt / Equity Ratio
0.601.05-0.13
Net Debt / EBITDA Ratio
-0.68-0.420.66
Net Debt / FCF Ratio
-0.52-0.300.28
Asset Turnover
0.350.29-
Inventory Turnover
4.299.97-
Quick Ratio
0.330.381.73
Current Ratio
0.660.561.91
Return on Equity (ROE)
-108.52%-151.43%-
Return on Assets (ROA)
-22.86%-21.96%-
Return on Capital Employed (ROCE)
-78.80%-137.30%-27.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024
Period Ending
Oct '26 Dec '25 Dec '24
Earnings Yield
-11.19%-7.28%-6.66%
FCF Yield
-9.55%-5.53%-10.77%
Buyback Yield / Dilution
-5.93%-10.65%-